MARKET

CERS

CERS

Cerus
NASDAQ
2.510
-0.090
-3.46%
After Hours: 2.549 +0.039 +1.56% 19:40 05/14 EDT
OPEN
2.640
PREV CLOSE
2.600
HIGH
2.717
LOW
2.500
VOLUME
2.35M
TURNOVER
--
52 WEEK HIGH
3.150
52 WEEK LOW
1.150
MARKET CAP
502.93M
P/E (TTM)
-50.5030
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERS last week (0504-0508)?
Weekly Report · 4d ago
Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis
Seeking Alpha · 4d ago
Cerus management to meet with Craig-Hallum
TipRanks · 05/07 02:35
Cerus COO Vivek K. Jayaraman sells 16,667 shares for $50,001
PUBT · 05/05 22:32
Top 3 Health Care Stocks That May Collapse This Month
Benzinga · 05/04 12:44
Weekly Report: what happened at CERS last week (0427-0501)?
Weekly Report · 05/04 09:38
Cerus Corporation Earnings Call Signals Profitable Growth
TipRanks · 05/02 00:22
Cerus Touches 52-Week High After 1Q Revenue Increases
Dow Jones · 05/01 18:51
More
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.